William Fricker

William Fricker

Plus aucun poste en cours
63 ans
Health Technology
Consumer Services
Process Industries

Profil

William Fricker formerly worked at Immunomedics, Inc., as Controller from 2018 to 2020, Eleison Pharmaceuticals, Inc., as Chief Financial Officer from 2022 to 2023, NRX Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer in 2021, J.
M.
Huber Micropowders, Inc., as VP, Global Controller & Chief Accounting Officer, NeuroTrauma Sciences LLC, as Chief Financial Officer from 2023 to 2024, and Annovis Bio, Inc., as Chief Financial Officer from 2024 to 2025.
Mr. Fricker received his undergraduate degree from The Pennsylvania State University.

Anciens postes connus de William Fricker

SociétésPosteFin
ANNOVIS BIO, INC. Directeur Financier/CFO 27/03/2025
Directeur Financier/CFO 01/04/2024
Directeur Financier/CFO 01/01/2023
NRX PHARMACEUTICALS, INC. Directeur Financier/CFO 30/08/2021
IMMUNOMEDICS, INC. Comptroller/Controller/Auditor 01/10/2020
Voir l'expérience en détail de William Fricker

Formation de William Fricker

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

2

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Process Industries

  1. Bourse
  2. Insiders
  3. William Fricker